Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sen-Han Yang"'
Autor:
Hao-Kang Li, Tai-Sheng Wu, Yi-Chiu Kuo, Ching-Wen Hsiao, Hsiu-Ping Yang, Chia-Yun Lee, Pei-Ju Leng, Zih-Fei Cheng, Sen-Han Yang, Yang-Liang Lin, Shih-Chia Hsiao, Sai-Wen Tang
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Hao-Kang Li, Chia-Yun Lee, Sai-Wen Tang, Hsiu-Ping Yang, Yan-Da Lai, Janet Pan, Tai-Sheng Wu, Shih-Chia Hsiao, Sen-Han Yang, Yan-Liang Lin, Ching-Wen Hsiao, Zih-Fei Cheng
Publikováno v:
Cancers, Vol 13, Iss 2724, p 2724 (2021)
Cancers
Volume 13
Issue 11
Cancers
Volume 13
Issue 11
Simple Summary Chimeric antigen receptor T cell therapy has shown its potency against hematologic malignancies in autologous settings but also limited success against solid tumors with severe adverse events, including fatal cases of cytokine releasin
Autor:
Tai-Sheng Wu, Hao-Kang Li, Ching-Wen Hsiao, Yi-Hung Ou, Zih-Fei Cheng, Hsiu-Ping Yang, Sen-Han Yang, Chia-Yun Lee, Yan-Liang Lin, Thorsten Graef, Sai-Wen Tang, Sonny Hsiao
Publikováno v:
Cancer Research. 82:5573-5573
Introduction Autologous CAR-T has improved clinical outcomes in hematological malignancies; however need remains to improve the toxicities, relapse rates, treatment delays and costs. ACE1831 is a novel, off-the-shelf Antibody Conjugated Effector cell
Autor:
Ching-Wen Hsiao, Zih-Fei Cheng, Chia-Yun Lee, Tai-Sheng Wu, Shih-Chia Hsiao, Hao-Kang Li, Janet Pan, Wei-Lun Lo, Yan-Liang Lin, Yan-Da Lai, Sen-Han Yang, Sai-Wen Tang, Hsiu-Ping Yang
Publikováno v:
Late-breaking abstracts.
Background Autologous or allogeneic natural killer (NK) cells possess efficient cytotoxicity against tumor cells without severe side effects such as CRS or graft-versus-host disease (GvHD). In addition to chimeric antigen receptor (CAR) strategy, ant